Qualitative Findings From a Survey on Patient Experiences and Satisfaction with Lung Cancer Screening

Overview

Journal Cancer Control

Specialty Oncology

Date 2023 Mar 27

PMID 36971270

Authors

Jaileene Perez-Morales

Rashmi Pathak

Monica Reyes

Haley Tolbert

Rajwantee Tirbene

Jhanelle E Gray

Vani N Simmons

Matthew B Schabath

Gwendolyn P Quinn

Affiliations

Soon will be listed here.

Abstract

Background: To reveal successes and potential limitations of the lung cancer screening program, we conducted a survey that included both quantitative and open-ended questions to measure patient experiences and satisfaction with screening.

Methods: We report on the five open-ended items related to barriers to returning for screening, experience with other cancer prevention screenings, positive and negative experiences, and suggestions for improving future appointments. The open-ended responses were analyzed using constant comparison method and inductive content analysis.

Results: Respondents (182 patients, 86% response rate for open-ended questions) provided generally positive comments about their lung cancer screening experience. Negative comments were related to desire for more information about results, long wait times for results, and billing issues. Suggestions for improvements included: scheduling on-line appointments and text or email reminders, lower costs, and responding to uncertainty about eligibility criteria.

Conclusion: Findings provide insights about patient experiences and satisfaction with lung cancer screening which is important given low uptake. Ongoing patient-centered feedback may improve the lung cancer screening experience and increase follow-up screening rates.

References

van Meerbeeck J, Franck C . Lung cancer screening in Europe: where are we in 2021?. Transl Lung Cancer Res. 2021; 10(5):2407-2417. PMC: 8182708. DOI: 10.21037/tlcr-20-890. View

Leighl N, Nirmalakumar S, Ezeife D, Gyawali B . An Arm and a Leg: The Rising Cost of Cancer Drugs and Impact on Access. Am Soc Clin Oncol Educ Book. 2021; 41:1-12. DOI: 10.1200/EDBK_100028. View

Crosbie P, Balata H, Evison M, Atack M, Bayliss-Brideaux V, Colligan D . Second round results from the Manchester 'Lung Health Check' community-based targeted lung cancer screening pilot. Thorax. 2018; 74(7):700-704. PMC: 6585285. DOI: 10.1136/thoraxjnl-2018-212547. View

Carter-Harris L, Gould M . Multilevel Barriers to the Successful Implementation of Lung Cancer Screening: Why Does It Have to Be So Hard?. Ann Am Thorac Soc. 2017; 14(8):1261-1265. DOI: 10.1513/AnnalsATS.201703-204PS. View

Lin Y, Fu M, Ding R, Inoue K, Jeon C, Hsu W . Patient Adherence to Lung CT Screening Reporting & Data System-Recommended Screening Intervals in the United States: A Systematic Review and Meta-Analysis. J Thorac Oncol. 2021; 17(1):38-55. PMC: 8692358. DOI: 10.1016/j.jtho.2021.09.013. View

Van Haren R, Delman A, Turner K, Waits B, Hemingway M, Shah S . Impact of the COVID-19 Pandemic on Lung Cancer Screening Program and Subsequent Lung Cancer. J Am Coll Surg. 2020; 232(4):600-605. PMC: 7947221. DOI: 10.1016/j.jamcollsurg.2020.12.002. View

Hirsch E, New M, Brown S, Baron A, Malkoski S . Patient Reminders and Longitudinal Adherence to Lung Cancer Screening in an Academic Setting. Ann Am Thorac Soc. 2019; 16(10):1329-1332. DOI: 10.1513/AnnalsATS.201902-152RL. View

Wang G, Baggett T, Pandharipande P, Park E, Percac-Lima S, Shepard J . Barriers to Lung Cancer Screening Engagement from the Patient and Provider Perspective. Radiology. 2019; 290(2):278-287. DOI: 10.1148/radiol.2018180212. View

Ersek J, Eberth J, McDonnell K, Strayer S, Sercy E, Cartmell K . Knowledge of, attitudes toward, and use of low-dose computed tomography for lung cancer screening among family physicians. Cancer. 2016; 122(15):2324-31. DOI: 10.1002/cncr.29944. View

10.

Raz D, Wu G, Consunji M, Nelson R, Kim H, Sun C . The Effect of Primary Care Physician Knowledge of Lung Cancer Screening Guidelines on Perceptions and Utilization of Low-Dose Computed Tomography. Clin Lung Cancer. 2017; 19(1):51-57. PMC: 8794575. DOI: 10.1016/j.cllc.2017.05.013. View

11.

Hoddinott S, Bass M . The dillman total design survey method. Can Fam Physician. 2011; 32:2366-8. PMC: 2328022. View

12.

Tailor T, Tong B, Gao J, Roy Choudhury K, Rubin G . A Geospatial Analysis of Factors Affecting Access to CT Facilities: Implications for Lung Cancer Screening. J Am Coll Radiol. 2019; 16(12):1663-1668. DOI: 10.1016/j.jacr.2019.06.020. View

13.

Elo S, Kyngas H . The qualitative content analysis process. J Adv Nurs. 2008; 62(1):107-15. DOI: 10.1111/j.1365-2648.2007.04569.x. View

14.

Aberle D, Adams A, Berg C, Black W, Clapp J, Fagerstrom R . Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365(5):395-409. PMC: 4356534. DOI: 10.1056/NEJMoa1102873. View

15.

Sands J, Tammemagi M, Couraud S, Baldwin D, Borondy-Kitts A, Yankelevitz D . Lung Screening Benefits and Challenges: A Review of The Data and Outline for Implementation. J Thorac Oncol. 2020; 16(1):37-53. DOI: 10.1016/j.jtho.2020.10.127. View

16.

Moyer V . Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014; 160(5):330-8. DOI: 10.7326/M13-2771. View

17.

Percac-Lima S, Ashburner J, Atlas S, Rigotti N, Flores E, Kuchukhidze S . Barriers to and Interest in Lung Cancer Screening Among Latino and Non-Latino Current and Former Smokers. J Immigr Minor Health. 2019; 21(6):1313-1324. DOI: 10.1007/s10903-019-00860-2. View

18.

Collett G, Durcinoska I, Rankin N, Blinman P, Barnes D, Anderiesz C . Patients' experience of lung cancer care coordination: a quantitative exploration. Support Care Cancer. 2018; 27(2):485-493. DOI: 10.1007/s00520-018-4338-3. View

19.

Lam A, Aggarwal R, Cheung S, Stewart E, Darling G, Lam S . Predictors of participant nonadherence in lung cancer screening programs: a systematic review and meta-analysis. Lung Cancer. 2020; 146:134-144. DOI: 10.1016/j.lungcan.2020.05.013. View

20.

Becker N, Motsch E, Trotter A, Heussel C, Dienemann H, Schnabel P . Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial. Int J Cancer. 2019; 146(6):1503-1513. DOI: 10.1002/ijc.32486. View